- Home
- XPEV vs KRYS Comparison
XPEV vs KRYS Comparison
Compare XPEV & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XPEV | KRYS |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | China | United States |
| Employees | 19884 | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 10.3B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | XPEV | KRYS |
|---|---|---|
| Price | $13.34 | $372.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | $23.08 | ★ $297.60 |
| AVG Volume (30 Days) | ★ 6.4M | 329.9K |
| Earning Date | 05-20-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 128.00 |
| EPS | N/A | ★ 1.83 |
| Revenue | N/A | ★ $389,130,000.00 |
| Revenue This Year | $25.76 | $38.74 |
| Revenue Next Year | $25.98 | $32.53 |
| P/E Ratio | ★ N/A | $206.37 |
| Revenue Growth | N/A | ★ 33.94 |
| 52 Week Low | $11.77 | $130.50 |
| 52 Week High | $28.20 | $378.15 |
Technical Indicators
Market Signals| Indicator | XPEV | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 40.03 | 74.24 |
| Support Level | N/A | $244.43 |
| Resistance Level | $18.35 | N/A |
| Average True Range (ATR) | 0.44 | 13.46 |
| MACD | -0.10 | 4.35 |
| Stochastic Oscillator | 42.86 | 86.97 |
Price Performance
Historical ComparisonAbout XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold about 430,000 EVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.